Journal
BLOOD REVIEWS
Volume 31, Issue 1, Pages 47-56Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.blre.2016.08.003
Keywords
Genotyping; Bleeding disorder; Hemophilia; von Willebrand disease
Categories
Funding
- Canadian Institute for Health Research Fellowship
- Association of Hemophilia Clinic Directors of Canada (AHCDC)
Ask authors/readers for more resources
Phenotypic assays are first-line in terms of diagnostic testing for inherited bleeding disorders. However, since the characterization of the genes that encode coagulation factors in the 1980s, significant progress has been made in translating this knowledge for diagnostic and therapeutic purposes. For the hemophilias, molecular genetic testing can be used to determine carrier status, establish a prenatal diagnosis and predict the likelihood of inhibitor development or anaphylaxis in response to infused coagulation factor concentrates. In contrast, for von Willebrand disease (VWD), significant recent advances in our understanding of the molecular genetic basis of the disease have allowed for the development of rational approaches to genetic diagnostics. Questions remain however, about this complex genetic disorder and how to incorporate emerging knowledge into diagnostic strategies. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available